PDCD1 and neoplasm: This indicates a reprogramming that promotes an exacerbated immune response rather than immunosuppression (59).Beyond their direct effects on Tregs, anti-PD-1 therapy can also influence immunosuppression mediated by tumor-associated macrophages, which induces Treg through PD-1.